Key Enhancement: Precise ileum-targeted delivery

Delivery System: 3D Microstructure for Intestine Targeting (3DμS® -IT)

Indication: Adult patients with primary immunoglobulin A nephropathy (IgAN) at risk of disease progression

Key Enhancement: The unique petal-like structure enables gastric retention.

Delivery System: 3D Microstructure for Gastric Retention (3DμS® -GR)

Indication:

• To reduce the risk of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF).
• For the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in adult patients who have undergone hip or knee replacement surgery.
• For the treatment of DVT and PE，and for the reduction in the risk of recurrent DVT and PE in adult patients following initial therapy.
• Treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent VTE in pediatric patients from birth and older after at least 5 days of initial anticoagulant treatment.

Key Enhancement: Single dosing with dual precise timed-release, addressing both sleep initiation and sleep maintenance difficulties in patients with insomnia.

Delivery System: 3D Microstructure for Modified Release (3DμS® -MR)

Indication: Insomnia characterized by difficulty falling asleep and/or early morning awakening

Key Enhancement: Improved oral bioavailability of peptide therapeutics

Delivery System: 3D Microstructure for Oral Macromolecules（3DμS^® -OM）

Indication: The drug is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues

Key Enhancement: To enhance the oral bioavailability of poorly soluble drugs

Delivery System: 3D Microstructure for Solubility Enhancement  (3DμS® -SE)

Indication:

• Fungal infections caused by susceptible organisms involving the skin, hair, nails, and mucous membranes.
• Fungal infections caused by susceptible organisms involving the skin and subcutaneous tissues.
• Systemic mycoses.